Pharmaceutical Information |
Drug Name |
Fusidic acid |
Drug ID |
BADD_D00980 |
Description |
An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed) It acts by inhibiting translocation during protein synthesis. It is often used topically in creams and eyedrops but is available in systemic formulations including tablets and injections. |
Indications and Usage |
For the treatment of bacterial infections. |
Marketing Status |
approved; investigational |
ATC Code |
D06AX01; D09AA02; J01XC01; S01AA13 |
DrugBank ID |
DB02703
|
KEGG ID |
D04281
|
MeSH ID |
D005672
|
PubChem ID |
3000226
|
TTD Drug ID |
D0X7XG
|
NDC Product Code |
12836-0315 |
UNII |
59XE10C19C
|
Synonyms |
Fusidic Acid | Acid, Fusidic | Stanicide | Fusidin | Silver Fusidate | Fusidate, Silver | Fucithalmic | Fusidate Sodium | Sodium, Fusidate | Fusidic Acid, Sodium Salt | Sodium Fusidate | Fusidate, Sodium |
|
Chemical Information |
Molecular Formula |
C31H48O6 |
CAS Registry Number |
6990-06-3 |
SMILES |
CC1C2CCC3(C(C2(CCC1O)C)C(CC4C3(CC(C4=C(CCC=C(C)C)C(=O)O)OC(=O)C)C)O)C |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|